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coincidence of RAD and CAD, irrespective of RAD
severity. Furthermore, the prevalence of no CAD in
nonsignificant (5 patients), borderline (2 patients), and
significant (2 patients) RAD was low.
These results would support the conclusion that
the presence of atherosclerotic RAD warrants a
search for CAD, to the point of coronary catheter-
ization if clinically appropriate.
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Predictive Accuracy of Echocardiographic Response of
Mildly Dyssynergic Myocardial Segments to
Low-Dose Dobutamine
Jan H. Cornel, MD, Jeroen J. Bax, MD, Abdou Elhendy, MD, Don Poldermans, MD,
Jean-Louis J. Vanoverschelde, MD, and Paolo M. Fioretti, MD
In patients with chronic coronary artery disease,resting contractile dysfunction may be caused by
myocardial necrosis, hibernation,1 or repetitive stun-
ning.2 Detection of contractile reserve during the in-
fusion of low-dose dobutamine indicates that the seg-
ment is viable and recovery of function may occur
after coronary revascularization.3 Indeed, many stud-
ies have used low-dose dobutamine echocardiography
to predict improvement of wall motion after revascu-
larization and showed sensitivities ranging from 74%
to 97% and specificities ranging from 69% to
96%.4–11 Most studies focused on prediction of recov-
ery of segments with severe wall motion abnormalities
(severe hypokinesia, akinesia), because segments with
mild hypokinesia are already considered viable inde-
pendent of their response to dobutamine. However,
the few available data showed that many hypokinetic
segments exhibiting contractile reserve during dobut-
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FIGURE 1. Ordinate shows patients with renal artery stenosis in terms of severity (<40%, 40% to 60%, >60%). Abscissa shows num-
bers of patients. In each group, patients are separated in terms of severity of their CAD. Severity of CAD was equally distributed in
each group and in the population as a whole. Three-vessel CAD was the most common (*p <0.05).
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amine did not improve in function after revasculariza-
tion, resulting in a low specificity.9,10 This is a partic-
ular important issue, since improvement of function
after revascularization is associated with increased
long-term survival.12 Therefore, we compared the sen-
sitivity and specificity of low-dose dobutamine echo-
cardiography to predict functional recovery in seg-
ments with severe wall motion abnormalities versus
segments with mild wall motion abnormalities.
• • •
Consecutive patients (n 5 91) with chronic stable
coronary artery disease and regional wall motion ab-
normalities on resting echocardiography were in-
cluded in the study (Table I). The patients were al-
ready scheduled for revascularization (surgery in 85
and angioplasty in 7); the decision to revascularize
was based only on clinical criteria. All patients under-
went low-dose dobutamine echocardiography within 1
month of revascularization without intervening
events. Beta blockers were withdrawn 36 hours before
the test; all other cardiac medication was continued. A
2-dimensional echocardiogram (in standard apical and
parasternal views) was recorded at rest. Dobutamine
was infused intravenously at doses of 5 and 10 mg/
kg/min (5 minutes at each dose). Continuous monitor-
ing of the echocardiogram was obtained during the
test and the images were recorded on videotape at the
last minute of both stages. The images were also
digitized (Vingmed CFM 800) and displayed in quad-
screen format. The interpretation of echocardiograms
was performed by 2 experienced observers blinded to
clinical data. For analysis of echocardiograms we used
a 16-segment model. Wall motion, including wall
thickening, of each segment was scored on a 5-point
scoring system: 1 5 normal, 2 5 mildly hypokinetic,
3 5 severely hypokinetic, 4 5 akinetic, and 5 5
dyskinetic. Wall thickening was primarily utilized for
the classification of wall motion, preempting the prob-
lem of postoperative paradoxical septal motion. Ad-
ditionally, in order to reduce the confounding effects
of tethering, segmental wall thickening was analyzed
frame by frame during the first half of systole.
Myocardial viability was judged present in a dys-
synergic segment when wall motion during the infu-
sion of low-dose dobutamine improved by at least 1
point of the scoring system, with the exception of
dyskinesia becoming akinesia. To compare the diag-
nostic accuracy of low-dose dobutamine echocardiog-
raphy in mildly dyssynergic segments versus severely
dyssynergic segments, the segments were divided into
2 groups: group I consisted of the mildly hypokinetic
segments and group II consisted of the severely hy-
pokinetic, akinetic, and dyskinetic segments.
To assess recovery of function, resting 2-dimen-
sional echocardiograms were obtained in all revascu-
larized patients before and 3 months after cardiac
revascularization. Follow-up echocardiograms were
compared with the corresponding resting images be-
fore revascularization, without knowledge of the do-
butamine studies. For each segment, recovery of func-
tion was defined as an improvement of $1 grade,
again with the exception of dyskinesia becoming aki-
nesia. We have previously reported a high inter- and
intraobserver agreement for classification of resting
wall motion (agreement 84% and 87%) and response
to low-dose dobutamine (agreement 92% and 94%) in
a comparable patient group.5
Data are presented as mean 6 SD. Univariate
analysis for categorical variables was performed using
the chi-square test with Yates’ correction. Sensitivity
and specificity figures and diagnostic accuracies were
based on their standard definitions and are presented
with corresponding 95% confidence intervals. Differ-
ences in sensitivities and specificities between se-
verely dyssynergic and mildly dyssynergic segments
were determined by the McNemar test. A p value
,0.05 was considered statistically significant.
Six hundred forty-three segments (44%) showed
FIGURE 1. Flow chart showing the presence/absence of contrac-
tile reserve and functional outcome after revascularization in
segments with severe (top) and mild (bottom) wall motion abnor-
malities. LDDE 5 low-dose dobutamine echocardiography.
TABLE I Baseline Characteristics of the Study Group
Gender (M/F) 73/18
Age (yr) 60 6 9
Previous CABG 10
Previous myocardial infarction
Q/non-Q wave 65/26
Angina (NYHA class) 2.3 6 0.7
Functional class 1.6 6 0.8
Coronary arteriography
1-vessel disease 8
2-vessel disease 21
3-vessel disease 61
LVEF (%) 31.7 6 11.1
Range (%) 13–35
Numbers represent absolute numbers of patients.
CABG 5 coronary artery bypass grafting; LVEF 5 left ventricular angio-
graphic ejection fraction; NYHA 5 New York Heart Association.
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abnormal wall motion. Of these segments, 21 were
excluded because of inadequate revascularization
(based on review of the surgery/angioplasty reports),
leaving 622 for the final analysis; 263 segments (42%)
showed mild dyssynergy (group I) and 359 (58%)
segments showed severe dyssynergy (group II). The
severely dyssynergic segments were supplied by more
stenotic vessels (140 segments by a total occluded
artery, 165 by a vessel with .70% stenosis, and 54 by
vessels with a 50% to 70% stenosis) than the mildly
dyssynergic segments (33 by a total occluded artery,
117 by a .70% stenosis, and 113 by a 50% to 70%
stenosis).
After revascularization 173 segments (28%) im-
proved in function, 413 (66%) remained unchanged,
and 36 (6%) deteriorated. Of the 263 group I seg-
ments, 84 (32%) showed recovery of function, 158
(60%) remained unchanged, and 21 (8%) deteriorated.
Of the 359 group II segments, 89 (25%) showed
recovery of function (including 46 severely hypoki-
netic, 41 akinetic, and 2 dyskinetic segments). Recov-
ery of function occurred significantly more often in
group I than in group II (32% vs 25%, p ,0.05).
During low-dose dobutamine, a contractile reserve
was elicited in 329 segments (53%), whereas 293
segments (47%) did not improve during the infusion
of low-dose dobutamine. In particular, 191 group I
segments (73%) and 138 group II segments (38%)
(including 59 severely hypokinetic and 79 akinetic)
exhibited a contractile reserve. Group I segments
showed improvement significantly more often during
dobutamine: 73% versus 38% (p ,0.05, Figure 1).
Sensitivities were comparable in groups I and II (96%
vs 89%). The specificity was significantly lower in
group I (39% vs 78%, p ,0.05, Table II). Similarly,
the diagnostic accuracy was lower in group I (57% vs
81%, p ,0.05). Sensitivities in mildly hypokinetic
segments were comparable between patients with and
without Q waves on the electrocardiogram. Although
the specificity in mildly hypokinetic segments was
lower in patients without Q waves (compared to pa-
tients with a Q wave), these values were not signifi-
cantly different (29%, 95% confidence interval 19% to
39% vs 48%, 95% confidence interval 38% to 58%).
• • •
Dobutamine echocardiography allows assessment
of myocardial viability and prediction of functional
recovery after revascularization.4–11 In severely dys-
synergic myocardium, the diagnostic accuracy of the
test is high, but recent reports suggest a lower accu-
racy in segments with mild dyssyn-
ergy.9,10 In the current study we
compared the accuracy in segments
with severe and mild dyssynergy.
Sensitivity was high for both catego-
ries. Specificity was high in seg-
ments with severe dyssynergy, but
was significantly lower in segments
with mild dyssynergy, indicating
overestimation of recovery in these
segments. This finding has important
implications since currently all ‘‘vi-
ability’’ studies use recovery of function as the gold
standard for myocardial viability, thus suggesting that
low-dose dobutamine echocardiography may not be
useful in mildly hypokinetic segments. The low spec-
ificity of low-dose dobutamine echocardiography in
these segments may be attributed to the following
phenomena:
1. Many hypokinetic segments may represent a
mixture of subendocardial scar and normal myocardi-
um.13 During dobutamine stimulation, the normal
myocardium may become hyperkinetic (while the sub-
endocardial infarct zone remains akinetic), resulting in
apparent normokinesia. These segments will not re-
cover function after revascularization. This hypothesis
emphasizes the need for the distinction between the
terms viability and recovery of function, as suggested
in 2 recent editorials.14,15 On the other hand, when
hypokinesia is caused by the presence of hibernating
myocardium, recovery of function may occur after
revascularization. Newer techniques with enhanced
resolution, enabling us to differentiate between endo-
cardial and epicardial wall motion, may overcome
these shortcomings and improve specificity of low-
dose dobutamine echocardiography. The fact that
specificity tended to be lower in patients with a non–
Q-wave infarction further substantiates the idea that
many hypokinetic segments did contain subendocar-
dial scar tissue. Moreover, the hypokinetic segments
were subtended by less severe stenoses, also arguing
in favor of subendocardial scar in these segments.
2. Tethering by adjacent akinetic segments may
have caused irreversible hypokinesia. Recent studies
have shown that the ‘‘biphasic response’’ to dobut-
amine may be more accurate in predicting functional
recovery.11,16 This biphasic response to dobutamine is
likely to be caused by the presence of a severe (crit-
ical) stenosis supplying the dyssynergic segment; after
the initial recruitment of contractility, the stenosis
becomes flow limiting at higher dosages of dobut-
amine, resulting in ischemia, reflected by worsening
of wall motion.14,17 The combination of low- and
high-dose dobutamine may be able to discriminate
between subendocardial scar and hibernating myocar-
dium.
Finally, all studies have used recovery of function
as the end point in viability studies. Kaul, however,
has recently pointed out that relief of ischemia, or the
prevention of remodeling may clinically be more im-
portant end points than functional recovery.14,17 It can
be hypothesized that the presence of subendocardial
TABLE II Sensitivities, Specificities, and Diagnostic Accuracies With 95%
Confidence Intervals in the Entire Group and in Subgroups (mild vs severe
dyssynergy)
Sens. (%) 95% CI Spec. (%) 95% CI DA (%) 95% CI
Entire group 92 80–100 62 57–67 66 63–69
Mild dyssynergy 96 92–100 39* 32–46 57* 51–63
Severe dyssynergy 89 82–96 78 73–83 81 77–85
*p ,0.05 versus severe segments with dyssynergy.
95% CI 5 95% confidence interval; DA 5 diagnostic accuracy; Sens. 5 sensitivity; Spec. 5 specificity.
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scar (and thus viability of the remaining myocardium)
may be important in preventing left ventricular remod-
eling and long-term prognosis.18
In conclusion, these data further substantiate
the hypothesis that low-dose dobutamine echocar-
diography has a relatively low specificity in seg-
ments with mild dyssynergy. This phenomenon
can, at least in part, be attributed to the presence of
subendocardial scar.
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Insulin Resistance in Patients With Familial Combined
Hyperlipidemia and Coronary Artery Disease
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Familial combined hyperlipidemia (FCH) is an al-teration in the metabolism of lipoproteins initially
described in a study of family members of young
survivors of myocardial infarction.1 The etiology of
FCH is unknown because the phenotype is variable
and the expression of the disease is affected by ge-
netic, metabolic, and environmental factors.2 FCH has
a prevalence in the general population of 0.5% to 2%
and between 15% and 20% in subjects with premature
cardiovascular disease.3 The common factor in sub-
jects with FCH is the increase in low-density lipopro-
tein (LDL) or very low density lipoprotein (VLDL), or
both, with elevations in the apolipoprotein B levels
and, frequently, low levels of high-density lipoprotein
(HDL), abnormal composition of lipoproteins, central
trunk obesity, hyperinsulinemia, and abnormal glu-
cose tolerance.4,5 These associations highlight the
considerable metabolic heterogeneity of the FCH con-
dition and arteriosclerosis.6 In the present study we
have investigated insulin resistance (quantified using
the minimal model of glucose metabolism modified by
the administration of insulin) and other known cardio-
vascular disease risk factors in patients with FCH
subgrouped according to the presence or absence of
ischemic heart disease (IHD).
• • •
Patients (33 men) were diagnosed as having FCH
after clinical and biochemical assessments of the pro-
bands and first-degree relatives. All patients selected
were nonsmokers or ex-smokers for at least 1 year.
Diagnosis was based on: the presence of hyperlipid-
emia of variable phenotypes IIa, IIb, or IV in first-
degree relatives of $2 generations, family history of
premature arteriosclerosis, elevated concentrations of
apoprotein B in plasma (.1.20 g/L), and absence of
xanthomas in the proband and in first-degree relatives.
The lipoprotein phenotypes were as described by
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